Providing AI supported dermatology solutions in partnership with the NHS
Reducing costs and adding valuable benefits
DERM, our unique AI technology, supports clinicians in their assessment of skin lesions. These range from malignant and pre-malignant lesions to benign lesions.
The Skin Analytics system also enables local dermatologists to review referred cases remotely, allowing them to direct patients to the best assessment or treatment option
Skin Analytics achieves Class IIa UKCA Mark for DERM. The UK’s first and only Class IIa certified AI dermatology device
Now a Class IIa medical device, DERM, uses machine learning algorithms to recognise the most common malignant, pre-malignant and benign skin lesions, including melanoma – the fifth most common cancer in the UK. Using a decade’s worth of research and development on skin lesions, it is designed to accelerate patient diagnosis and relieve pressure on the healthcare system.
Discussing the systematic review of skin cancer datasets in The Lancet: Skin Analytics response.
We were delighted to see research into the publicly available skin cancer datasets many use to train AI systems to...
Skin Analytics Receives NHSX Award for AI-Based Skin Cancer Tool
Deployment of unique diagnosis aid to be boosted across the NHS Currently deployed in University Hospitals Birmingham...